#drugmaker — Public Fediverse posts

https://www.europesays.com/dk/62265/ Novo Nordisk hires 2,000 as it reshapes workforce after cutting 7,800 jobs last year: Report #drugmaker #layoffs #NovoNordisk

Trump’s 100% tariffs on drugs could cost you more at the pharmacy

The Trump administration will impose tariffs of as much as 100% on certain imported medicines, albeit with several…
#UnitedStates #US #USA #company #cost #DonaldTrump #drug #drugmaker #Import #medicine #Nationalsecurity #price #tariff #thursday #trump #TrumpAdministration #U.S. #WhiteHousestatement
https://www.europesays.com/2892538/

https://www.europesays.com/people/6041/ Trump’s 100% tariffs on drugs could cost you more at the pharmacy #company #cost #DonaldTrump #drug #drugmaker #import #medicine #NationalSecurity #price #tariff #thursday #Trump #TrumpAdministration #US #WhiteHouseStatement

https://www.europesays.com/dk/49271/ Novo Nordisk’s Strategic Board Nomination #BoardNomination #CompetitiveMarket #drugmaker #leadership #MarketPosition #Mars #NovoNordisk #PoulWeihrauch #strategy #USObesity

https://www.europesays.com/dk/39029/ Feds warn Ozempic and Wegovy maker over failure to report side-effects from weight-loss drugs #AdverseEffects #AdverseEvents #DavidBurrow #drugmaker #FoodAndDrugAdministration #InjectableDrugs #NovoNordisk #WarningLetter

President Donald Trump to visit Cincinnati to tout push for lower drug prices

President Donald Trump is planning a visit to Greater Cin…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #Administration #aggressiveeffort #Americans #cincinnatinextweek #drugmaker #government-hostedwebsite #Headlines #highcost #launch #lowdrugprice #Medication #part #prescriptiondrugprice #PresidentDonaldTrump #Topstories #TopStories #Trump #weightloss
https://www.newsbeep.com/us/508182/

President Donald Trump to visit Cincinnati to tout push for lower drug prices

President Donald Trump is planning a visit to Greater Cin…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #Administration #aggressiveeffort #Americans #cincinnatinextweek #drugmaker #government-hostedwebsite #Headlines #highcost #launch #lowdrugprice #Medication #part #prescriptiondrugprice #PresidentDonaldTrump #Topstories #TopStories #Trump #weightloss
https://www.newsbeep.com/us/508182/

https://www.europesays.com/ie/163833/ Is Eli Lilly a Millionaire Maker? #DrugMaker #Éire #EliLilly #Health #HealthCare #Healthcare #IE #Ireland #WeightLossDrug

Is Eli Lilly a Millionaire Maker?

Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
#NewsBeep #News #Healthcare #AU #Australia #drugmaker #EliLilly #Health #weightlossdrug
https://www.newsbeep.com/au/263631/

Denmark’s economy runs on Novo. Will the drugmaker’s troubles slim it down?

(Bloomberg) — Denmark’s status as one of the few countries in Europe with an expanding economy rests in…
#Denmark #Danmark #DK #Europe #Europa #EU #bloomberg #Danisheconomy #denmark #drugmaker #LasOlsen #NovoNordisk #NovoNordiskFoundation #StatisticsDenmark
https://www.europesays.com/2299059/

Bloomberg: #UK #drugmaker #AstraZeneca plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other #European #pharmaceutical #companies ahead of looming #tariffs on #imported #medicines.

Bloomberg: #UK #drugmaker #AstraZeneca plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other #European #pharmaceutical #companies ahead of looming #tariffs on #imported #medicines.

DATE: July 11, 2025 at 05:30PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

.@OIGatHHS won’t oppose #drugmaker payment for #companiondiagnostic

https://t.co/dtyiMh9qNC

#medtech

Here are any URLs found in the article text:

https://t.co/dtyiMh9qNC

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: July 11, 2025 at 05:30PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

.@OIGatHHS won’t oppose #drugmaker payment for #companiondiagnostic

https://t.co/dtyiMh9qNC

#medtech

Here are any URLs found in the article text:

https://t.co/dtyiMh9qNC

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: July 11, 2025 at 05:30PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

.@OIGatHHS won’t oppose #drugmaker payment for #companiondiagnostic

https://t.co/dtyiMh9qNC

#medtech

Here are any URLs found in the article text:

https://t.co/dtyiMh9qNC

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

DATE: July 11, 2025 at 05:30PM
SOURCE: BioWorld MedTech

Direct article link at end of text block below.

.@OIGatHHS won’t oppose #drugmaker payment for #companiondiagnostic

https://t.co/dtyiMh9qNC

#medtech

Here are any URLs found in the article text:

https://t.co/dtyiMh9qNC

#medtech

Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .

-------------------------------------------------

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------

#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

German drugmaker Boehringer eyes Japan as Asia hub with $346m investment

TOKYO — German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base for Asia and Oceania. The p…
#Japan #JP #JapanNews #$346m #asia #Boehringer #drugmaker #Eyes #German #hub #investment #news
https://www.alojapan.com/1302293/german-drugmaker-boehringer-eyes-japan-as-asia-hub-with-346m-investment/

German drugmaker Boehringer eyes Japan as Asia hub with $346m investment

TOKYO — German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base for Asia and Oceania. The p…
#Japan #JP #JapanNews #$346m #asia #Boehringer #drugmaker #Eyes #German #hub #investment #news
https://www.alojapan.com/1302293/german-drugmaker-boehringer-eyes-japan-as-asia-hub-with-346m-investment/

GSK Plc will pay #23andMe Holding Co. $20M for #GeneticTesting company’s vast #trove of #consumer #DNAData, extending a 5 yr collaboration that’s allowed the #drugmaker to mine #geneticdata as it researches new #medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized #DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really? #privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data

GSK Plc will pay #23andMe Holding Co. $20M for #GeneticTesting company’s vast #trove of #consumer #DNAData, extending a 5 yr collaboration that’s allowed the #drugmaker to mine #geneticdata as it researches new #medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized #DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really? #privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data

GSK Plc will pay #23andMe Holding Co. $20M for #GeneticTesting company’s vast #trove of #consumer #DNAData, extending a 5 yr collaboration that’s allowed the #drugmaker to mine #geneticdata as it researches new #medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized #DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really? #privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data

GSK Plc will pay #23andMe Holding Co. $20M for #GeneticTesting company’s vast #trove of #consumer #DNAData, extending a 5 yr collaboration that’s allowed the #drugmaker to mine #geneticdata as it researches new #medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized #DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really? #privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data

GSK Plc will pay #23andMe Holding Co. $20M for #GeneticTesting company’s vast #trove of #consumer #DNAData, extending a 5 yr collaboration that’s allowed the #drugmaker to mine #geneticdata as it researches new #medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized #DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really? #privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data

#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B

#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.

#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.

#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b

#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B

#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.

#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.

#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b

#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B

#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.

#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.

#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b

#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B

#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.

#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.

#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b